ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2026

Corrigendum to "Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial": [Ann Oncol 36 (2025) 775-785].

E Felip et al.PubMed ↗Publisher ↗

No numbers read from the abstract.